View Cover
A phase 4 study is under way on the real-world outcomes with ocriplasmin.
Modifier 59 — You’re Probably Using It a Lot, But Are You Using It Correctly?
A primer on patient selection through postop rehabilitation
New technologies could facilitate diagnosis.
Matching modality to pathology
Telescope Implant Restores Central Sight in Certain Patients with AMD
By Karen Appold, contributing writer
Advanced disease forms pose special challenges.
An old antibiotic saves the day.
By Jerry Helzner, contributing editor
Making It So
